Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer

Condition:   Ovarian Carcinoma Interventions:   Drug: pegylated liposomal doxorubicin (PLD) + carboplatin (CD);   Drug: carboplatin + paclitaxel (CP) Sponsors:   Konkuk University Medical Center;   Seoul National University Hospital;   National Cancer Center, Korea;   Asan Medical Center;   The Catholic University of Korea;   Samsung Medical Center;   Chung-Ang University Hosptial, Chung-Ang University College of Medicine;   Ajou  University;   Severance Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials